Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

South Korea jails three Samsung Electronics executives over evidence destroyed in probe of alleged fraud

Published 09/12/2019, 09:21
Updated 09/12/2019, 09:25
South Korea jails three Samsung Electronics executives over evidence destroyed in probe of alleged fraud
0593xq
-
005930
-
028260
-
207940
-

SEOUL (Reuters) - A South Korean court on Monday jailed three executives of Samsung (LON:0593xq) Electronics (KS:005930) for their role in a plot that included burying computers under factory floors at its biotech affiliate, in an investigation of alleged accounting fraud.

Prosecutors began investigating the suspected fraud at Samsung Biologics (KS:207940) after South Korea's financial watchdog complained the firm's value had been inflated by 4.5 trillion won (3 billion pounds) in 2015.

The episode is the latest legal trouble for South Korea's top conglomerate, whose leader Jay Y. Lee is embroiled in separate trials in a corruption scandal involving former President Park Geun-hye.

"The boldness of the defendants' criminal acts was beyond the public's imagination and stunned society," Judge Soh Byung-seok said, handing down sentences of up to two years.

"Most South Korean people want Samsung ... to become the world's top-class company contributing to the country's economy," the judge added.

"However, if such growth is based on breaches and unlawfulness, it will not be applauded."

Lawyers for the executives were not immediately available for comment. Samsung Electronics declined to comment, and representatives of Samsung Biologics were not immediately available for comment.

Prosecutors accused the executives of ordering employees at the biopharmaceutical firm to destroy and conceal internal documents, as authorities investigated accusations of a violation of accounting rules there.

The efforts included inserting nearly two dozen computers and notebooks as well as computer servers in spaces under the floors of Samsung Biologics factories near the capital, Seoul, they added.

Civic groups have said the alleged fraud aimed to boost the value of Samsung Biologics' parent Samsung C&T (KS:028260), adding this was achieved by smoothing the way for a 2015 deal involving the parent and consolidating Lee's control of the group.

Lee faces charges of having bribed former President Park in return for seeking support in Samsung's succession planning.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.